ENTITY
CanSino Biologics

CanSino Biologics (6185 HK)

186
Analysis
Health CareChina
CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based tuberculosis vaccines for human use. CanSino Biologics serves customers worldwide.
more
28 Aug 2021 05:51

Asia Shorts: Shenzhou, Xiaomi, BABA, BYD, Renesas, Shionogi, Freee, Celltrion, LGD, Novatek, Wan Hai

The Insight looks at movements in short interest across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
240 Views
Share
20 Aug 2021 21:18

Asia Shorts: Meituan, Geely, Kuaishou, COLI, Toshiba, Freee, NCSOFT, SK Tel, Yang Ming, Wan Hai, EMC

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
279 Views
Share
08 Aug 2021 07:56

China Healthcare Weekly (Aug.6)

The insight mainly analyzed increasing short-term volatility in healthcare sector by newly released education policy, Nanjing COVID-19 outbreak,...

Logo
279 Views
Share
27 Jun 2021 08:56

China Healthcare Weekly (Jun.25)

This article analyzed the results of 5th national volume-based purchase, the new announcement on the centralized procurement of artificial joints,...

Logo
223 Views
Share
09 Jun 2021 09:15

CanSino Biologics (688185.CH/6185.HK) - Time for Corner Overtaking?

The inhaled COVID-19 vaccine of CanSino is applying for emergency use in China,which worth the attention of investors.The article analyzed the...

Logo
260 Views
Share
x